We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Roivant Sciences announced the launch of Respivant Sciences, a biopharmaceutical company focused on the lives of patients suffering from serious respiratory diseases...
PhaseBio is using its ELP platform to extend the half-life of proteins, peptides and other large molecules to create injectable drugs that can be administered less frequently.